TABLE OF CONTENTS
TABLE OF CONTENTS I
LIST OF FIGURES XIII
LIST OF CHARTS XXVII
EXECUTIVE SUMMARY 1
U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 12
PROCEDURE CODES INVESTIGATED 12
MARKETS INCLUDED 13
KEY REPORT UPDATES 15
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 19
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29
 
DISEASE OVERVIEW 30
2.1 INTRODUCTION 30
2.2 TYPES OF ARRHYTHMIAS 31
2.2.11 Atrial Fibrillation 31
2.2.12 Bradycardia 32
2.2.13 Conduction Disorders 32
2.2.13.1 Bundle Branch Block 32
2.2.13.2 Heart Block 33
2.2.13.3 Long QT Syndrome (LQTS) 34
2.2.14 Premature Contractions: PACs and PVCs 34
2.2.15 Tachycardia 35
2.2.16 Ventricular Fibrillation 36
2.2.17 Other Rhythm Disorders 36
2.2.17.1 Adams-Stokes Disease 36
2.2.17.2 Atrial Flutter 37
2.2.17.3 Sick Sinus syndrome 37
2.2.17.4 Sinus Arrhythmia 37
2.2.17.5 Wolff-Parkinson-White Syndrome (WPW) 37
2.2.18 Types of Arrhythmia in Children 37
2.3 HEART FAILURE 38
2.4 CARDIAC ARREST 39
2.5 PATIENT DEMOGRAPHICS 40
2.5.11 Atrial Fibrillation 40
2.5.12 Bradycardia 40
2.5.13 Conduction Disorders 41
2.5.14 Premature Contractions – PACs and PVCs 42
2.5.15 Tachycardia 43
2.5.16 Ventricular Fibrillation 43
2.5.17 Other Rhythm Disorders 44
 
PRODUCT ASSESSMENT 45
3.1 INTRODUCTION 45
3.2 PRODUCT PORTFOLIOS 45
3.2.1 Pacemakers 45
3.2.2 Implantable Cardioverter Defibrillators (ICDs) 48
3.2.3 Cardiac Resynchronization Therapy (CRT) Devices 50
3.2.4 Cardiac Leads 52
3.2.5 External Defibrillators 54
3.2.6 Lab Systems 56
3.2.6.1 Introduction 56
3.2.6.2 3D Mapping Systems 56
3.2.6.3 EP Recording Systems 57
3.2.6.4 Remote Steering Systems 58
3.2.6.5 RF Ablation Generator 58
3.2.6.6 ICE Systems 58
3.2.6.7 Product Matrix for Lab Systems: Core Companies 60
3.2.7 Diagnostic EP Catheters 61
3.2.7.1 Introduction 61
3.2.7.2 Diagnostic EP Catheters 61
3.2.7.3 ICE Catheters 62
3.2.8 Cardiac Ablation Catheters 65
3.2.8.1 Introduction 65
3.2.8.2 RF Ablation Catheters 66
3.2.8.3 Alternative Energy Catheters 67
3.2.8.4 High Intensity Focused Ultrasound 67
3.3 FDA RECALLS 70
3.3.1 Abbott 70
3.3.1.1 Pacemakers 70
3.3.1.2 Implantable Cardioverter Defibrillators (ICDs) 71
3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices 72
3.3.1.4 Cardiac Leads 73
3.3.1.5 EP Lab Devices 73
3.3.1.6 Cardiac Ablation Catheter 74
3.3.2 Biosense Webster 75
3.3.2.1 EP Lab Devices 75
3.3.3 Boston Scientific 76
3.3.3.1 Pacemakers 76
3.3.3.2 Implantable Cardioverter Defibrillators (ICDs) 82
3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices 83
3.3.3.4 Cardiac Leads 86
3.3.3.5 EP Lab Devices 86
3.3.3.6 RF Ablation Catheter 87
3.3.4 Cardiac Science 88
3.3.4.1 Automated External Defibrillator (AED) 88
3.3.5 Medtronic 89
3.3.5.1 Pacemakers 89
3.3.5.2 Implantable Cardioverter Defibrillators (ICDs) 90
3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices 93
3.3.5.4 Cardiac Leads 96
3.3.5.5 EP Lab Devices 96
3.3.6 MicroPort 97
3.3.6.1 Implantable Cardioverter Defibrillators (ICDs) 97
3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices 99
3.3.7 Philips Healthcare 101
3.3.7.1 Automated External Defibrillator (AED) 101
3.3.8 Stryker Sustainability Solutions 103
3.3.8.1 Diagnostic EP Catheters 103
3.3.9 ZOLL 105
3.3.9.1 Automated External Defibrillator (AED) 105
3.3.9.2 Wearable Cardioverter Defibrillator (WCD) 105
3.4 CLINICAL TRIALS 106
3.4.1 Pacemakers 106
3.4.2 Implantable Cardioverter Defibrillators (ICDs) 110
3.4.3 Cardiac Resynchronization Therapy (CRT) Devices 113
3.4.4 Cardiac Leads 118
3.4.5 External Defibrillators 124
3.4.6 Lab Systems 125
3.4.6.1 3D Mapping Systems 125
3.4.6.2 EP Recording Systems 127
3.4.6.3 RF Ablation Generators 128
3.4.6.4 ICE Systems 129
3.4.7 Diagnostic EP Catheters 131
3.4.7.1 Diagnostic Catheter 131
3.4.8 Cardiac Ablation Catheter 133
3.4.8.1 RF Ablation Catheters 133
3.4.8.2 Cryoablation Catheters 136
3.4.8.3 Laser Ablation Catheters 142
U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 144
4.1 INTRODUCTION 144
4.2 MARKET OVERVIEW 146
4.3 TREND ANALYSIS BY SEGMENT 152
4.4 DRIVERS AND LIMITERS 156
4.4.1 Market Drivers 156
4.4.2 Market Limiters 157
4.5 COMPETITIVE MARKET SHARE ANALYSIS 161
4.6 MERGERS AND ACQUISITIONS 167
4.7 COMPANY PROFILES 168
4.7.1 Abbott 168
4.7.2 Biosense Webster 169
4.7.3 Biotronik 170
4.7.4 Boston Scientific 171
4.7.5 Cardiac Science 173
4.7.6 GE Healthcare 174
4.7.7 Medtronic 175
4.7.8 MicroPort 176
4.7.9 ZOLL 178
4.8 SWOT ANALYSIS 179
4.8.1 Abbott 179
4.8.2 Biosense Webster 181
4.8.3 Biotronik 182
4.8.4 Boston Scientific 183
4.8.5 Cardiac Science 184
4.8.6 GE Healthcare 185
4.8.7 Medtronic 186
4.8.8 MicroPort 187
4.8.9 ZOLL 189
PROCEDURE NUMBERS 190
5.1 INTRODUCTION 190
5.2 PROCEDURES 191
5.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures 191
PACEMAKER MARKET 194
6.1 INTRODUCTION 194
6.1.1 Single and Dual-Chamber Devices 194
6.1.2 MRI-Compatible Pacemaker 195
6.1.3 Leadless Pacemaker 195
6.1.4 Initial Placement and Replacement of Pacemakers 196
6.2 MARKET OVERVIEW 197
6.3 MARKET ANALYSIS AND FORECAST 202
6.3.1 Total Pacemaker Market 202
6.3.2 Total Single-Chamber Pacemaker Market 204
6.3.2.1 Initial Placement Single-Chamber Pacemaker Market 209
6.3.2.2 Replacement Single-Chamber Pacemaker Market 211
6.3.3 Total Dual-Chamber Pacemaker Market 213
6.3.3.1 Initial Placement Dual-Chamber Pacemaker Market 218
6.3.3.2 Replacement Dual-Chamber Pacemaker Market 220
6.3.4 Leadless Pacemaker Market 222
6.4 PRICE ANALYSIS 225
6.5 DRIVERS AND LIMITERS 226
6.5.1 Market Drivers 226
6.5.2 Market Limiters 227
6.6 COMPETITIVE MARKET SHARE ANALYSIS 229
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET 233
7.1 INTRODUCTION 233
7.2 MARKET OVERVIEW 235
7.3 MARKET ANALYSIS AND FORECAST 239
7.3.1 Total ICD Market 239
7.3.2 Total Single-Chamber ICD Market 241
7.3.2.1 Initial Placement Single-Chamber ICD Market 246
7.3.2.2 Replacement Single-Chamber ICD Market 248
7.3.3 Total Dual-Chamber ICD Market 250
7.3.3.1 Initial Placement Dual-Chamber ICD Market 255
7.3.3.2 Replacement Dual-Chamber ICD Market 257
7.3.4 S-ICD Market 259
7.4 DRIVERS AND LIMITERS 262
7.4.1 Market Drivers 262
7.4.2 Market Limiters 263
7.5 COMPETITIVE MARKET SHARE ANALYSIS 265
CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET 269
8.1 INTRODUCTION 269
8.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 269
8.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 269
8.2 MARKET OVERVIEW 270
8.3 MARKET ANALYSIS AND FORECAST 275
8.3.1 Total CRT Market 275
8.3.2 Total CRT-P Market 278
8.3.2.1 Initial Placement CRT-P Market 282
8.3.2.2 Replacement CRT-P Market 284
8.3.3 Total CRT-D Market 286
8.3.3.1 Initial Placement CRT-D Market 290
8.3.3.2 Replacement CRT-D Market 292
8.4 DRIVERS AND LIMITERS 294
8.4.1 Market Drivers 294
8.4.2 Market Limiters 295
8.5 COMPETITIVE MARKET SHARE ANALYSIS 298
CARDIAC LEADS MARKET 302
9.1 INTRODUCTION 302
9.1.1 Replacement of Leads 303
9.2 MARKET OVERVIEW 304
9.3 MARKET ANALYSIS AND FORECAST 308
9.3.1 Total Cardiac Lead Market 308
9.3.2 Pacing Lead Market 310
9.3.3 Defibrillation Lead Market 312
9.3.4 LV Lead Market 314
9.4 DRIVERS AND LIMITERS 316
9.4.1 Market Drivers 316
9.4.2 Market Limiters 317
9.5 COMPETITIVE MARKET SHARE ANALYSIS 319
ELECTROCARDIOGRAPHY MONITORING MARKET 323
10.1 INTRODUCTION 323
10.1.1 Holter Monitoring 324
10.1.2 Stress Testing 324
10.2 MARKET OVERVIEW 325
10.3 MARKET ANALYSIS AND FORECAST 329
10.3.1 Total Resting ECG Device Market 329
10.3.1.1 Hospital-Based Resting ECG Device Market 333
10.3.1.2 Total Office-Based Resting ECG Device Market 335
10.3.1.2.1 Purpose-Built Office-Based Resting ECG Device Market 339
10.3.1.2.2 PC-Based Office-Based Resting ECG Device Market 341
10.3.2 Total Stress Testing Device Market 343
10.3.2.1 Hospital-Based Stress Testing Device Market 348
10.3.2.2 Office-Based Stress Testing Device Market 350
10.3.3 Total Holter Monitoring Recorder Market 352
10.3.3.1 Hospital-Based Holter Monitoring Recorder Market 357
10.3.3.2 Office-Based Holter Monitoring Recorder Market 359
10.3.3.3 IDTF Holter Monitoring Recorder Market 361
10.4 DRIVERS AND LIMITERS 363
10.4.1 Market Drivers 363
10.4.2 Market Limiters 364
10.5 COMPETITIVE MARKET SHARE ANALYSIS 366
LAB SYSTEMS MARKET 370
11.1 INTRODUCTION 370
11.1.1 3D Mapping Systems 370
11.1.2 EP Recording Systems 371
11.1.3 Remote Steering Systems 371
11.1.4 RF Ablation Generator 371
11.1.5 ICE System 372
11.2 MARKET OVERVIEW 373
11.3 MARKET ANALYSIS AND FORECAST 377
11.3.1 3D Mapping Market 377
11.3.2 EP Recording Market 379
11.3.3 RF Ablation Generator Market 381
11.3.4 Remote Steering System Market 383
11.4 DRIVERS AND LIMITERS 385
11.4.1 Market Drivers 385
11.4.2 Market Limiters 386
11.5 COMPETITIVE MARKET SHARE ANALYSIS 388
DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS MARKET 392
12.1 INTRODUCTION 392
12.1.1 Diagnostic Electrophysiology Catheters 392
12.1.2 Reprocessed Catheters 393
12.1.3 Intracardiac Echocardiography 393
12.2 MARKET OVERVIEW 394
12.3 MARKET ANALYSIS AND FORECAST 398
12.3.1 Total Diagnostic Electrophysiology Catheters Market 398
12.3.2 Total EP Conventional Catheter Market 401
12.3.2.1 Fixed EP Catheter Market 406
12.3.2.2 Steerable EP Catheter Market 408
12.3.3 EP Advanced Catheter Market 410
12.3.4 ICE Diagnostic Catheter Market 412
12.4 DRIVERS AND LIMITERS 415
12.4.1 Market Drivers 415
12.4.2 Market Limiters 416
12.5 COMPETITIVE MARKET SHARE ANALYSIS 418
CARDIAC ABLATION CATHETER MARKET 422
13.1 INTRODUCTION 422
13.2 MARKET OVERVIEW 424
13.3 MARKET ANALYSIS AND FORECAST 428
13.3.1 Cardiac Ablation Catheter Market 428
13.3.2 RF Ablation Catheter Market 430
13.3.2.1 Irrigated RF Ablation Catheter Market 435
13.3.2.2 Non-Irrigated RF Ablation Catheter Market 437
13.3.3 Cryoablation Catheter Market 439
13.4 DRIVERS AND LIMITERS 441
13.4.1 Market Drivers 441
13.4.2 Market Limiters 442
13.5 COMPETITIVE MARKET SHARE ANALYSIS 444
APPENDIX I: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GENERATOR MARKET 448
14.1 INTRODUCTION 448
14.2 MARKET ANALYSIS AND FORECAST 449
14.3 DRIVERS AND LIMITERS 451
14.3.1 Market Drivers 451
14.3.2 Market Limiters 452
14.4 COMPETITIVE MARKET SHARE ANALYSIS 454
APPENDIX II: CRYOABLATION GENERATOR MARKET 457
15.1 INTRODUCTION 457
15.2 MARKET ANALYSIS AND FORECAST 458
15.3 DRIVERS AND LIMITERS 460
15.3.1 Market Drivers 460
15.3.2 Market Limiters 461
15.4 COMPETITIVE MARKET SHARE ANALYSIS 463
APPENDIX III: EXTERNAL DEFIBRILLATOR MARKET 464
16.1 INTRODUCTION 464
16.1.1 Automated External Defibrillator 464
16.1.2 Wearable Cardioverter Defibrillator 464
16.2 MARKET OVERVIEW 466
16.3 MARKET ANALYSIS AND FORECAST 471
16.3.1 Total External Defibrillator Market 471
16.3.2 Automated External Defibrillator Market 474
16.3.3 Wearable Cardioverter Defibrillator Market 476
16.4 DRIVERS AND LIMITERS 478
16.4.1 Market Drivers 478
16.4.2 Market Limiters 479
16.5 COMPETITIVE MARKET SHARE ANALYSIS 481
ABBREVIATIONS 484

Chart 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025 3
Chart 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview, U.S., 2018 & 2025 3
Chart 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025 149
Chart 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2018 150
Chart 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2025 151
Chart 4 4: Growth Rates by Segment, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2016 – 2025 155
Chart 4 5: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 166
Chart 5 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 – 2025 193
Chart 6 1: Pacemaker Market by Segment, U.S., 2015 – 2025 199
Chart 6 2: Pacemaker Market Breakdown, U.S., 2018 200
Chart 6 3: Pacemaker Market Breakdown, U.S., 2025 201
Chart 6 4: Total Pacemaker Market, U.S., 2015 – 2025 203
Chart 6 5: Single-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025 206
Chart 6 6: Total Single-Chamber Pacemaker Market, U.S., 2015 – 2025 208
Chart 6 7: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 – 2025 210
Chart 6 8: Replacement Single-Chamber Pacemaker Market, U.S., 2015 – 2025 212
Chart 6 9: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025 215
Chart 6 10: Total Dual-Chamber Pacemaker Market, U.S., 2015 – 2025 217
Chart 6 11: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025 219
Chart 6 12: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025 221
Chart 6 13: Leadless Pacemaker Market, U.S., 2015 – 2025 224
Chart 6 14: Leading Competitors, Pacemaker Market, U.S., 2018 232
Chart 7 1: ICD Market by Segment, U.S., 2015 – 2025 236
Chart 7 2: ICD Market Breakdown, U.S., 2018 237
Chart 7 3: ICD Market Breakdown, U.S., 2025 238
Chart 7 4: Total ICD Market, U.S., 2015 – 2025 240
Chart 7 5: Single-Chamber ICD Market by Segment, U.S., 2015 – 2025 243
Chart 7 6: Total Single-Chamber ICD Market, U.S., 2015 – 2025 245
Chart 7 7: Initial Placement Single-Chamber ICD Market, U.S., 2015 – 2025 247
Chart 7 8: Replacement Single-Chamber ICD Market, U.S., 2015 – 2025 249
Chart 7 9: Dual-Chamber ICD Market by Segment, U.S., 2015 – 2025 252
Chart 7 10: Total Dual-Chamber ICD Market, U.S., 2015 – 2025 254
Chart 7 11: Initial Placement Dual-Chamber ICD Market, U.S., 2015 – 2025 256
Chart 7 12: Replacement Dual-Chamber ICD Market, U.S., 2015 – 2025 258
Chart 7 13: S-ICD Market, U.S., 2015 – 2025 261
Chart 7 14: Leading Competitors, ICD Market, U.S., 2018 268
Chart 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 – 2025 272
Chart 8 2: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2018 273
Chart 8 3: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2025 274
Chart 8 4: Total CRT Market, U.S., 2015 – 2025 277
Chart 8 5: CRT-P Market by Segment, U.S., 2015 – 2025 279
Chart 8 6: Total CRT-P Market, U.S., 2015 – 2025 281
Chart 8 7: Initial Placement CRT-P Market, U.S., 2015 – 2025 283
Chart 8 8: Replacement CRT-P Market, U.S., 2015 – 2025 285
Chart 8 9: CRT-D Market by Segment, U.S., 2015 – 2025 287
Chart 8 10: Total CRT-D Market, U.S., 2015 – 2025 289
Chart 8 11: Initial Placement CRT-D Market, U.S., 2015 – 2025 291
Chart 8 12: Replacement CRT-D Market, U.S., 2015 – 2025 293
Chart 8 13: Leading Competitors, CRT Market, U.S., 2018 301
Chart 9 1: Cardiac Lead Market by Segment, U.S., 2015 – 2025 305
Chart 9 2: Cardiac Lead Market Breakdown, U.S., 2018 306
Chart 9 3: Cardiac Lead Market Breakdown, U.S., 2025 307
Chart 9 4: Total Cardiac Lead Market, U.S., 2015 – 2025 309
Chart 9 5: Pacing Lead Market, U.S., 2015 – 2025 311
Chart 9 6: Defibrillation Lead Market, U.S., 2015 – 2025 313
Chart 9 7: LV Lead Market, U.S., 2015 – 2025 315
Chart 9 8: Leading Competitors, Cardiac Lead Market, U.S., 2018 322
Chart 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 – 2025 326
Chart 10 2: Electrocardiography Monitoring Market Breakdown, U.S., 2018 327
Chart 10 3: Electrocardiography Monitoring Market Breakdown, U.S., 2025 328
Chart 10 4: Resting ECG Device Market by Segment, U.S., 2015 – 2025 330
Chart 10 5: Total Resting ECG Device Market, U.S., 2015 – 2025 332
Chart 10 6: Hospital-Based Resting ECG Device Market, U.S., 2015 – 2025 334
Chart 10 7: Office-Based Resting ECG Device Market by Segment, U.S., 2015 – 2025 336
Chart 10 8: Total Office-Based Resting ECG Device Market, U.S., 2015 – 2025 338
Chart 10 9: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 – 2025 340
Chart 10 10: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 – 2025 342
Chart 10 11: Stress Testing Device Market by Segment, U.S., 2015 – 2025 345
Chart 10 12: Total Stress Testing Device Market, U.S., 2015 – 2025 347
Chart 10 13: Hospital-Based Stress Testing Device Market, U.S., 2015 – 2025 349
Chart 10 14: Office-Based Stress Testing Device Market, U.S., 2015 – 2025 351
Chart 10 15: Holter Monitoring Recorder Market by Segment, U.S., 2015 – 2025 354
Chart 10 16: Total Holter Monitoring Recorder Market, U.S., 2015 – 2025 356
Chart 10 17: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025 358
Chart 10 18: Office-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025 360
Chart 10 19: IDTF Holter Monitoring Recorder Market, U.S., 2015 – 2025 362
Chart 10 20: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018 369
Chart 11 1: Lab Systems Market by Segment, U.S., 2015 – 2025 374
Chart 11 2: Lab Systems Market Breakdown, U.S., 2018 375
Chart 11 3: Lab Systems Market Breakdown, U.S., 2025 376
Chart 11 4: 3D Mapping Market, U.S., 2015 – 2025 378
Chart 11 5: EP Recording Market, U.S., 2015 – 2025 380
Chart 11 6: RF Ablation Generator Market, U.S., 2015 – 2025 382
Chart 11 7: Remote Steering System Market, U.S., 2015 – 2025 384
Chart 11 8: Leading Competitors, Lab Systems Market, U.S., 2018 391
Chart 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 – 2025 395
Chart 12 2: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2018 396
Chart 12 3: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2025 397
Chart 12 4: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 – 2025 400
Chart 12 5: EP Conventional Catheter Market by Segment, U.S., 2015 – 2025 403
Chart 12 6: Total EP Conventional Catheter Market, U.S., 2015 – 2025 405
Chart 12 7: Fixed EP Catheter Market, U.S., 2015 – 2025 407
Chart 12 8: Steerable EP Catheter Market, U.S., 2015 – 2025 409
Chart 12 9: EP Advanced Catheter Market, U.S., 2015 – 2025 411
Chart 12 10: ICE Diagnostic Catheter Market, U.S., 2015 – 2025 414
Chart 12 11: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018 421
Chart 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 – 2025 425
Chart 13 2: Cardiac Ablation Catheter Market Breakdown, U.S., 2018 426
Chart 13 3: Cardiac Ablation Catheter Market Breakdown, U.S., 2025 427
Chart 13 4: Cardiac Ablation Catheter Market, U.S., 2015 – 2025 429
Chart 13 5: RF Ablation Market by Segment, U.S., 2015 – 2025 432
Chart 13 6: Total RF Ablation Catheter Market, U.S., 2015 – 2025 434
Chart 13 7: Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025 436
Chart 13 8: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025 438
Chart 13 9: Cryoablation Catheter Market, U.S., 2015 – 2025 440
Chart 13 10: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018 447
Chart 14 1: ICE Generator Market, U.S., 2015 – 2025 450
Chart 14 2: Leading Competitors, ICE Generator Market, Europe, 2018 456
Chart 15 1: Cryoablation Generator Market, U.S., 2015 – 2025 459
Chart 16 1: External Defibrillator Market by Segment, U.S., 2015 – 2025 468
Chart 16 2: External Defibrillator Market Breakdown, U.S., 2018 469
Chart 16 3: External Defibrillator Market Breakdown, U.S., 2025 470
Chart 16 4: Total External Defibrillator Market, U.S., 2015 – 2025 473
Chart 16 5: Automated External Defibrillator Market, U.S., 2015 – 2025 475
Chart 16 6: Wearable Cardioverter Defibrillator Market, U.S., 2015 – 2025 477
Chart 16 7: Leading Competitors, External Defibrillator Market, U.S., 2018 483

Figure 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (1 of 2) 5
Figure 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (2 of 2) 5
Figure 1 3: Companies Researched in this Report 6
Figure 1 4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (1 of 2) 7
Figure 1 5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (2 of 2) 8
Figure 1 6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 – 2018 (1 of 3) 9
Figure 1 7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 – 2018 (2 of 3) 10
Figure 1 8: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 – 2018 (3 of 3) 11
Figure 1 9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered 12
Figure 1 10: Procedure Codes Investigated 12
Figure 1 11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (1 of 2) 13
Figure 1 12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (2 of 2) 14
Figure 1 13: Key Report Updates 15
Figure 1 14: Version History 15
Figure 3 1: Pacemaker Market Products by Company 47
Figure 3 2: ICD Market Products by Company 49
Figure 3 3: CRT Device Market Products by Company 51
Figure 3 4: Cardiac Leads Market Products by Company 53
Figure 3 5: External Defibrillator Market Products by Company 55
Figure 3 6: Lab Systems Market Products by Company 60
Figure 3 7: Diagnostic EP Catheter Market Products by Company 64
Figure 3 8: Cardiac Ablation Catheter Products by Company (1 of 2) 68
Figure 3 9: Cardiac Ablation Catheter Products by Company (2 of 2) 69
Figure 3 10: Class 2 Device Recall Assurity 70
Figure 3 11: Class 2 Device Recall Zenex 70
Figure 3 12: Class 2 Device Recall Accent family of pacemakers 70
Figure 3 13: Class 1 Device Recall Fortify, Fortify Assura 71
Figure 3 14: Class 1 Device Recall Fortify, Unify, Assura, including Quadra 71
Figure 3 15: Class 2 Device Recall Ellipse 72
Figure 3 16: Class 2 Device Recall Allure Quadra 72
Figure 3 17: Class 2 Device Recall Anthem, Allure 72
Figure 3 18: Class 2 Device Recall Nuance 73
Figure 3 19: Class 1 Device Recall Optisure HV lead 73
Figure 3 20: Class 3 Device Recall FIRMap 60mm Catheter 73
Figure 3 21: Class 2 Device Recall TactiSys Quartz Pack, PN004 400 74
Figure 3 22: Class 2 Device Recall SMARTABLATE RF Generator System 75
Figure 3 23: Class 2 Device Recall ESSENTIO Pacemaker 76
Figure 3 24: Class 2 Device Recall PROPONENT Pacemaker 76
Figure 3 25: Class 2 Device Recall ACCOLADE Pacemaker 76
Figure 3 26: Class 2 Device Recall PROPONENT SR Pacemaker 77
Figure 3 27: Class 2 Device Recall PROPONENT DR Pacemaker 77
Figure 3 28: Class 2 Device Recall PROPONENT EL DR Pacemaker 77
Figure 3 29: Class 2 Device Recall PROPONENT VDD SL Pacemaker 77
Figure 3 30: Class 2 Device Recall PROPONENT VDD SL Pacemaker 78
Figure 3 31: Class 2 Device Recall ACCOLADE MRI EL DR Pacemaker 78
Figure 3 32: Class 2 Device Recall ACCOLADE MRI DR Pacemaker 78
Figure 3 33: Class 2 Device Recall ACCOLADE MRI SR Pacemaker 78
Figure 3 34: Class 2 Device Recall ACCOLADE EL DR Pacemaker 79
Figure 3 35: Class 2 Device Recall ACCOLADE DR Pacemaker 79
Figure 3 36: Class 2 Device Recall ACCOLADE SR Pacemaker 79
Figure 3 37: Class 2 Device Recall ESSENTIO MRI EL DR Pacemaker 79
Figure 3 38: Class 2 Device Recall ESSENTIO MRI DR Pacemaker 80
Figure 3 39: Class 2 Device Recall ESSENTIO MRI SR Pacemaker 80
Figure 3 40: Class 2 Device Recall ESSENTIO DR Pacemaker 80
Figure 3 41: Class 2 Device Recall ESSENTIO SR Pacemaker 80
Figure 3 42: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker 81
Figure 3 43: Class 2 Device Recall ALTRUA 2 SR Pacemaker 81
Figure 3 44: Class 2 Device Recall ALTRUA 2 DR Pacemaker 81
Figure 3 45: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers 81
Figure 3 46: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT) 82
Figure 3 47: Class 2 Device Recall RESONATE EL ICD VR 82
Figure 3 48: Class 2 Device Recall RESONATE EL ICD DR 82
Figure 3 49: Class 2 Device Recall EMBLEM SICD, Model A209 82
Figure 3 50: Class 2 Device Recall SQRX 1010 Pulse Generator 83
Figure 3 51: Class 2 Device Recall EMBLEM MRI SICD Model 219 83
Figure 3 52: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator 83
Figure 3 53: Class 2 Device Recall VISIONIST X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) 83
Figure 3 54: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) 84
Figure 3 55: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker 84
Figure 3 56: Class 2 Device Recall VALITUDE CRTP Pacemaker 84
Figure 3 57: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker 84
Figure 3 58: Class 2 Device Recall VISIONIST CRTP Pacemaker 85
Figure 3 59: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker 85
Figure 3 60: Class 2 Device Recall RESONATE X4 CRTD 85
Figure 3 61: Class 2 Device Recall MOMENTUM X4 CRTD 85
Figure 3 62: Class 2 Device Recall VIGILANT X4 CRTD 86
Figure 3 63: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly 86
Figure 3 64: Class 2 Device Recall Maestro 4000 Cardiac Ablation System 86
Figure 3 65: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System 87
Figure 3 66: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters 87
Figure 3 67: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter 87
Figure 3 68: Class 2 Device Recall 9131 Defibrillator Electrodes 88
Figure 3 69: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator 89
Figure 3 70: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator 89
Figure 3 71: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies 90
Figure 3 72: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies 90
Figure 3 73: Class 2 Device Recall Medtronic EnTrust Escudo 91
Figure 3 74: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD 91
Figure 3 75: Class 1 Device Recall Visia AF MRI VR SureScan ICD 91
Figure 3 76: Class 1 Device Recall Visia AF VR ICD 92
Figure 3 77: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD 92
Figure 3 78: Class 2 Device Recall Evera ICD 92
Figure 3 79: Class 2 Device Recall Viva ICD 93
Figure 3 80: Class 2 Device Recall Percepta CRTP MRI SureScan 93
Figure 3 81: Class 2 Device Recall Percepta Quad CRTP MRI SureScan 93
Figure 3 82: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD 94
Figure 3 83: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD 94
Figure 3 84: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD 95
Figure 3 85: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan 95
Figure 3 86: Class 2 Device Recall InSync III 95
Figure 3 87: Class 2 Device Recall Medtronic, Temporary Pacing Lead System 96
Figure 3 88: Class 2 Device Recall Achieve Electrical Cable 96
Figure 3 89: Class 2 Device Recall Medtronic CryoConsole 96
Figure 3 90: Class 2 Device Recall Platinium DR 1510 97
Figure 3 91: Class 2 Device Recall Platinium VR 1210 97
Figure 3 92: Class 2 Device Recall Platinium DR DF4 1540 97
Figure 3 93: Class 2 Device Recall Platinium VR DF4 1240 98
Figure 3 94: Class 2 Device Recall PARADYM 98
Figure 3 95: Class 2 Device Recall OVATIO 98
Figure 3 96: Class 2 Device Recall INTENSIA 98
Figure 3 97: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator 99
Figure 3 98: Class 2 Device Recall Platinium CRTD 1741 99
Figure 3 99: Class 2 Device Recall Platinium CRT DF1 1711 99
Figure 3 100: Class 2 Device Recall PARADYM 100
Figure 3 101: Class 2 Device Recall OVATIO 100
Figure 3 102: Class 2 Device Recall INTENSIA 100
Figure 3 103: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator 101
Figure 3 104: Class 2 Device Recall Philips HeartStart FRx AED 101
Figure 3 105: Class 2 Device Recall Philips HeartStart (HS1) (Onsite/Home) AED 101
Figure 3 106: Class 3 Device Recall XL Defibrillator 102
Figure 3 107: Class 2 Device Recall Philips QCPR Meter CPR feedback device 102
Figure 3 108: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator 102
Figure 3 109: Class 2 Device Recall Philips HeartStart 102
Figure 3 110: Class 2 Device Recall BW Lasso 2515 ANV eco Variable Diagnostic EP Catheter 103
Figure 3 111: Class 2 Device Recall Reprocessed LASSO NAV eco Electrophysiology Catheter 103
Figure 3 112: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter 103
Figure 3 113: Class 2 Device Recall Stryker Sustainability Solutions Reprocessed BW Lasso 2515 NAV eco Variable Diagnostic 104
Figure 3 114: Class 2 Device Recall Stryker Sustainability Solutions 104
Figure 3 115: Class 2 Device Recall Daig Livewire Steerable and Supreme Fixed Curve Diagnostic Electrophysiology Catheters 104
Figure 3 116: Class 2 Class 2 Device Recall OneStep CPR Complete 105
Figure 3 117: Class 2 Device Recall LifeVest Wearable Defibrillator 105
Figure 3 118: SJM Brady MRI Post Approval Study 106
Figure 3 119: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) 107
Figure 3 120: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers 107
Figure 3 121: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan 107
Figure 3 122: BIO|MASTER.Edora Family Study 108
Figure 3 123: China Micra Transcatheter Pacing Study 108
Figure 3 124: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study) 108
Figure 3 125: Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The CAPAPAF-65 Study 109
Figure 3 126: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II 109
Figure 3 127: Observation of ImageReady™ MR Conditional Pacing System in China 109
Figure 3 128: Micra Transcatheter Pacing System Continued Access Study Protocol 110
Figure 3 129: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT) 110
Figure 3 130: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF) 111
Figure 3 131: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) 111
Figure 3 132: Extravascular ICD Pilot Study 111
Figure 3 133: Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies 112
Figure 3 134: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death 112
Figure 3 135: BIO|MASTER.Ilivia Family/Plexa 112
Figure 3 136: The REACT-ICD Trial (REACT-ICD) 113
Figure 3 137: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial 113
Figure 3 138: Can Cognitive Function be Improved by Cardiac Resynchronization Therapy? (COGNI-CRT) 114
Figure 3 139: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure - An Investigator-driven, Prospective, Parallel-group, Randomized, Open, Blinded Outcome Assessment (PROBE), Multi-center Trial Without Investigational Medical Products (Proof of Strategy Trial) 114
Figure 3 140: Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D 115
Figure 3 141: AV Optimization Delivered with Direct His Bundle Pacing, in Patients with Heart Failure, Long PR Without Left Bundle Branch Block: Randomized Multi-center Clinical Outcome Study. 115
Figure 3 142: Heart Failure with Preserved Ejection Fraction Treated by Cardiac Resynchronization Therapy Versus Rate Responsive Pacing: A Mechanistic Study 116
Figure 3 143: Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial) 116
Figure 3 144: Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients (BIO|PULSE) 116
Figure 3 145: A Multicentre Randomized Control Trial Comparing Standard Cardiac Resynchronization Pacing with Triventricular Pacing 117
Figure 3 146: Responders and Quadripolar LV Lead in CRT 117
Figure 3 147: Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint "Death or Non-planned Hospitalization for Heart Failure (HF)" in Patients with HF and Prolonged QRS 118
Figure 3 148: Plexa ICD Lead Registry 118
Figure 3 149: AXONE -Acute: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped with DF4 Connector 119
Figure 3 150: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR) 119
Figure 3 151: Avoid Transvenous Leads in Appropriate Subjects 120
Figure 3 152: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy 120
Figure 3 153: Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted with a Quartet Left Ventricular (LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated 121
Figure 3 154: Attain Stability™ Quad Clinical Study 121
Figure 3 155: Imaging Study of Lead Implant for His Bundle Pacing ((IMAGE-HBP)) 122
Figure 3 156: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation 122
Figure 3 157: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP) 122
Figure 3 158: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy 123
Figure 3 159: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing Magnetic Resonance Imaging, an Investigational Device Exemption (IDE) Study 123
Figure 3 160: Acute Extravascular Defibrillation Study 123
Figure 3 161: Quality of Cardiopulmonary Resuscitation Guided by AED vs Telephone-assistance 124
Figure 3 162: Accuracy of Instructional Diagrams for Automated External Defibrillator (AED) Pad Positioning 124
Figure 3 163: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) 125
Figure 3 164: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter 125
Figure 3 165: Real-time Electrogram Analysis for Drivers of AtRial Fibrillation (RADAR) 126
Figure 3 166: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia 126
Figure 3 167: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias 127
Figure 3 168: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment 127
Figure 3 169: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development 128
Figure 3 170: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 128
Figure 3 171: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System 129
Figure 3 172: INtra-procedural ultraSound Imaging for DEtermination of Atrial Wall Thickness and Acute Tissue Changes During Isolation of the Pulmonary Veins 129
Figure 3 173: EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry 130
Figure 3 174: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System 130
Figure 3 175: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter 131
Figure 3 176: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia 131
Figure 3 177: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness 132
Figure 3 178: FIRE AND ICE II Trial Pilot 133
Figure 3 179: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR) 133
Figure 3 180: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation 134
Figure 3 181: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 134
Figure 3 182: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter 135
Figure 3 183: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 135
Figure 3 184: Feasibility Study for Optically Guided Radiofrequency Ablation Catheter 135
Figure 3 185: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial 136
Figure 3 186: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter 136
Figure 3 187: ArcticLine Feasibility Study 136
Figure 3 188: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation 137
Figure 3 189: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation 137
Figure 3 190: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation 138
Figure 3 191: CoolLoop Paroxysmal Atrial Fibrillation 138
Figure 3 192: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation 139
Figure 3 193: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter 139
Figure 3 194: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) 140
Figure 3 195: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation 140
Figure 3 196: Cryterion Cardiac Cryoablation System First in Man Clinical Study 141
Figure 3 197: STOP Persistent AF 141
Figure 3 198: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure 141
Figure 3 199: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) 142
Figure 3 200: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation 142
Figure 3 201: Laser Ablation Study for trEatment of atRial Fibrillation (LASER) 143
Figure 3 202: A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF) 143
Figure 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025 (US$M) (1 of 2) 147
Figure 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 – 2025 (US$M) (2 of 2) 148
Figure 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 – 2025 (1 of 2) 153
Figure 4 4: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 – 2025 (2 of 2) 154
Figure 4 5: Drivers and Limiters, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 160
Figure 4 6: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (1 of 2) 164
Figure 4 7: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (2 of 2) 165
Figure 4 8: SWOT Analysis, Abbott (1 of 2) 179
Figure 4 9: SWOT Analysis, Abbott (2 of 2) 180
Figure 4 10: SWOT Analysis, Biosense Webster 181
Figure 4 11: SWOT Analysis, Biotronik 182
Figure 4 12: SWOT Analysis, Boston Scientific 183
Figure 4 13: SWOT Analysis, Cardiac Science 184
Figure 4 14: SWOT Analysis, GE Healthcare 185
Figure 4 15: SWOT Analysis, Medtronic 186
Figure 4 16: SWOT Analysis, MicroPort (1 of 2) 187
Figure 4 17: SWOT Analysis, MicroPort (2 of 2) 188
Figure 4 18: SWOT Analysis, ZOLL 189
Figure 5 1: Procedure Codes Investigated, U.S., 2018 190
Figure 5 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 – 2025 (1 of 2) 191
Figure 5 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 – 2025 (2 of 2) 192
Figure 6 1: Pacemaker Market by Segment, U.S., 2015 – 2025 (US$M) 198
Figure 6 2: Total Pacemaker Market, U.S., 2015 – 2025 202
Figure 6 3: Single-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025 (US$M) 205
Figure 6 4: Total Single-Chamber Pacemaker Market, U.S., 2015 – 2025 207
Figure 6 5: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 – 2025 209
Figure 6 6: Replacement Single-Chamber Pacemaker Market, U.S., 2015 – 2025 211
Figure 6 7: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 – 2025 (US$M) 214
Figure 6 8: Total Dual-Chamber Pacemaker Market, U.S., 2015 – 2025 216
Figure 6 9: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025 218
Figure 6 10: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 – 2025 220
Figure 6 11: Leadless Pacemaker Market, U.S., 2015 – 2025 223
Figure 6 12: Pricing Tiers, Pacemaker Market, U.S., 2018 225
Figure 6 13: Drivers and Limiters, Pacemaker Market, U.S., 2018 228
Figure 6 14: Leading Competitors, Pacemaker Market, U.S., 2018 231
Figure 7 1: ICD Market by Segment, U.S., 2015 – 2025 (US$M) 235
Figure 7 2: Total ICD Market, U.S., 2015 – 2025 239
Figure 7 3: Single-Chamber ICD Market by Segment, U.S., 2015 – 2025 (US$M) 242
Figure 7 4: Total Single-Chamber ICD Market, U.S., 2015 – 2025 244
Figure 7 5: Initial Placement Single-Chamber ICD Market, U.S., 2015 – 2025 246
Figure 7 6: Replacement Single-Chamber ICD Market, U.S., 2015 – 2025 248
Figure 7 7: Dual-Chamber ICD Market by Segment, U.S., 2015 – 2025 (US$M) 251
Figure 7 8: Total Dual-Chamber ICD Market, U.S., 2015 – 2025 253
Figure 7 9: Initial Placement Dual-Chamber ICD Market, U.S., 2015 – 2025 255
Figure 7 10: Replacement Dual-Chamber ICD Market, U.S., 2015 – 2025 257
Figure 7 11: S-ICD Market, U.S., 2015 – 2025 260
Figure 7 12: Drivers and Limiters, ICD Market, U.S., 2018 264
Figure 7 13: Leading Competitors, ICD Market, U.S., 2018 267
Figure 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 – 2025 (US$M) 271
Figure 8 2: Total CRT Market, U.S., 2015 – 2025 276
Figure 8 3: CRT-P Market by Segment, U.S., 2015 – 2025 (US$M) 278
Figure 8 4: Total CRT-P Market, U.S., 2015 – 2025 280
Figure 8 5: Initial Placement CRT-P Market, U.S., 2015 – 2025 282
Figure 8 6: Replacement CRT-P Market, U.S., 2015 – 2025 284
Figure 8 7: CRT-D Market by Segment, U.S., 2015 – 2025 (US$M) 286
Figure 8 8: Total CRT-D Market, U.S., 2015 – 2025 288
Figure 8 9: Initial Placement CRT-D Market, U.S., 2015 – 2025 290
Figure 8 10: Replacement CRT-D Market, U.S., 2015 – 2025 292
Figure 8 11: Drivers and Limiters, CRT Market, U.S., 2018 297
Figure 8 12: Leading Competitors, CRT Market, U.S., 2018 300
Figure 9 1: Cardiac Lead Market by Segment, U.S., 2015 – 2025 (US$M) 304
Figure 9 2: Total Cardiac Lead Market, U.S., 2015 – 2025 308
Figure 9 3: Pacing Lead Market, U.S., 2015 – 2025 310
Figure 9 4: Defibrillation Lead Market, U.S., 2015 – 2025 312
Figure 9 5: LV Lead Market, U.S., 2015 – 2025 314
Figure 9 6: Drivers and Limiters, Cardiac Lead Market, U.S., 2018 318
Figure 9 7: Leading Competitors, Cardiac Lead Market, U.S., 2018 321
Figure 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 – 2025 (US$M) 325
Figure 10 2: Resting ECG Device Market by Segment, U.S., 2015 – 2025 (US$M) 329
Figure 10 3: Total Resting ECG Device Market, U.S., 2015 – 2025 331
Figure 10 4: Hospital-Based Resting ECG Device Market, U.S., 2015 – 2025 333
Figure 10 5: Office-Based Resting ECG Device Market by Segment, U.S., 2015 – 2025 (US$M) 335
Figure 10 6: Total Office-Based Resting ECG Device Market, U.S., 2015 – 2025 337
Figure 10 7: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 – 2025 339
Figure 10 8: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 – 2025 341
Figure 10 9: Stress Testing Device Market by Segment, U.S., 2015 – 2025 (US$M) 344
Figure 10 10: Total Stress Testing Device Market, U.S., 2015 – 2025 346
Figure 10 11: Hospital-Based Stress Testing Device Market, U.S., 2015 – 2025 348
Figure 10 12: Office-Based Stress Testing Device Market, U.S., 2015 – 2025 350
Figure 10 13: Holter Monitoring Recorder Market by Segment, U.S., 2015 – 2025 (US$M) 353
Figure 10 14: Total Holter Monitoring Recorder Market, U.S., 2015 – 2025 355
Figure 10 15: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025 357
Figure 10 16: Office-Based Holter Monitoring Recorder Market, U.S., 2015 – 2025 359
Figure 10 17: IDTF Holter Monitoring Recorder Market, U.S., 2015 – 2025 361
Figure 10 18: Drivers and Limiters, Electrocardiography Monitoring Market, U.S., 2018 365
Figure 10 19: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018 368
Figure 11 1: Lab Systems Market by Segment, U.S., 2015 – 2025 (US$M) 373
Figure 11 2: 3D Mapping Market, U.S., 2015 – 2025 377
Figure 11 3: EP Recording Market, U.S., 2015 – 2025 379
Figure 11 4: RF Ablation Generator Market, U.S., 2015 – 2025 381
Figure 11 5: Remote Steering System Market, U.S., 2015 – 2025 383
Figure 11 6: Drivers and Limiters, Lab Systems Market, U.S., 2018 387
Figure 11 7: Leading Competitors, Lab Systems Market, U.S., 2018 (1 of 2) 390
Figure 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 – 2025 (US$M) 394
Figure 12 2: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 – 2025 399
Figure 12 3: EP Conventional Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 402
Figure 12 4: Total EP Conventional Catheter Market, U.S., 2015 – 2025 404
Figure 12 5: Fixed EP Catheter Market, U.S., 2015 – 2025 406
Figure 12 6: Steerable EP Catheter Market, U.S., 2015 – 2025 408
Figure 12 7: EP Advanced Catheter Market, U.S., 2015 – 2025 410
Figure 12 8: ICE Diagnostic Catheter Market, U.S., 2015 – 2025 413
Figure 12 9: Drivers and Limiters, Diagnostic Electrophysiology Catheters Market, U.S., 2018 417
Figure 12 10: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018 420
Figure 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 424
Figure 13 2: Cardiac Ablation Catheter Market, U.S., 2015 – 2025 428
Figure 13 3: RF Ablation Catheter Market by Segment, U.S., 2015 – 2025 (US$M) 431
Figure 13 4: Total RF Ablation Catheter Market, U.S., 2015 – 2025 433
Figure 13 5: Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025 435
Figure 13 6: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 – 2025 437
Figure 13 7: Cryoablation Catheter Market, U.S., 2015 – 2025 439
Figure 13 8: Drivers and Limiters, Cardiac Ablation Catheter Market, U.S., 2018 443
Figure 13 9: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018 446
Figure 14 1: ICE Generator Market, U.S., 2015 – 2025 449
Figure 14 2: Drivers and Limiters, ICE Generator Market, U.S., 2018 453
Figure 14 3: Leading Competitors, ICE Generator Market, U.S., 2018 455
Figure 15 1: Cryoablation Generator Market, U.S., 2015 – 2025 458
Figure 15 2: Drivers and Limiters, Cryoablation Generator Market, U.S., 2018 462
Figure 16 1: External Defibrillator Market by Segment, U.S., 2015 – 2025 (US$M) 467
Figure 16 2: Total External Defibrillator Market, U.S., 2015 – 2025 472
Figure 16 3: Automated External Defibrillator Market, U.S., 2015 – 2025 474
Figure 16 4: Wearable Cardioverter Defibrillator Market, U.S., 2015 – 2025 476
Figure 16 5: Drivers and Limiters, External Defibrillator Market, U.S., 2018 480
Figure 16 6: Leading Competitors, External Defibrillator Market, U.S., 2018 482

The "US Market Report Suite for Cardiac Rhythm Management Market Overview" includes analysis on the following companies currently active in this market:
Abbott
Biosense Webster
Biotronik
Boston Scientific
Cardiac Science
GE Healthcare
Medtronic
MicroPort
ZOLL
*Not all companies may be currently active in every segment. For more details contact an iData Research Product Advisor.